Acacia Subsidiary Acquires 13 Patents for Drug Delivery Technology
"Acacia continues to increase the number of patent portfolios we control in the medical technology sector," commented Paul Ryan, CEO. "Acacia is rapidly expanding its presence as a leader in patent licensing for both the technology and medical technology sectors."
ABOUT ACACIA RESEARCH CORPORATION
Acacia Research Corporations subsidiaries partner with inventors and patent owners, license the patents to corporate users, and share the revenue. Acacia Research Corporations subsidiaries control over 200 patent portfolios, covering technologies used in a wide variety of industries. Information about Acacia Research Corporation and its subsidiaries is available at www.acaciaresearchgroup.com and www.acaciaresearch.com.
Posted by Sean Fenske, Editor-in-Chief, MDT